跳至主要内容
临床试验/NCT02069210
NCT02069210Unknown不适用

The Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients

Mahidol University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年5月最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Immunologic parameters

研究概览

简要总结

The purpose of this study is to investigate the effect of transfusion of allogeneic (homologous) red cells on the immunologic parameters such as T-cells as well as natural killer cell count/function, various interleukins, TNF alpha and other immunologic relevant parameters on postoperative day 1,3 and 5-7 in patients undergoing spine surgery.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 - < 60 years
  • Patients underwent elective spine surgery
  • ASA classification 1-3

排除标准

  • Patients who have the concomitant condition
  • History of heart disease including, heart failure, coronary artery disease, hypertension treated with more than one medicament.
  • Serum creatinine > 1.5 mg/dL
  • Stroke, neurologic and mental deficits, epilepsy
  • General or local infection (site of surgery),
  • Coagulation disorders.
  • Intraoperative massive bleeding
  • Infection of the spine
  • Rheumatoid arthritis
  • Patients who had either of the following drug (aspirin, methotrexate, cyclosporine, qualaquin)

结局指标

主要结局

Immunologic parameters

时间窗: 7 days

Blood level of the following parameters on preoperative, postoperative day 1, 3, 5-7. 1. IL-1beta, IL-1ra, IL-2, IL-4, IL-5, IL-6, Il-7, IL-8, Il-9, Il-10, Il-12, Il-13, IL-15, Il-17,basic FGF (Fibroblast growth factors). 2. Cell Analytics - (mononuclear) T-Cells incl. killer cells, CD2, CD3, CD4, CD8, CD25, CD30, CD19, CD20, CD138, CD56, CD56, CD303, CD304, NK cytotoxicity (non-radioisotope), CTL cytotoxicity (non-radioisotope), T cell proliferation, B cell, T cell.

次要结局

  • To determine the effect of red cell transfusion on clinical relevant outcome parameters, such as myocardial infarction, infection rate, and length of hospital stay.(1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sirilak Suksompong

Associated Professor

Mahidol University

研究点 (1)

Loading locations...

相似试验